National reference standards for vaccines released in India

9 June 2016
gateway-of-india-big

The Indian Pharmacopeia Commission (IPC) has released the national reference standards, specifically referred as the Indian Pharmacopoeia Reference Substances (IPRS Vaccines), the first such initiative to be undertaken of its kind.

The standards would include IP monographs which act as the national reference standards for vaccines, according to Brand India Pharma.

The standards were released on the occasion of the 5th Expert Committee Meeting held in Kasauli, Himachal Pradesh, jointly organized by IPC and Central Drugs Laboratory (CDL). Representatives from D rug Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO) and Central Research Institute (CRI) were also present. Other related participants included stakeholders from vaccine manufacturing companies and representatives from PETA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical